Screening high risk populations for lung cancer
Menée à partir des données 2010-2018 des registres américains des cancers, cette étude analyse l'effet, sur l'incidence et le stade au diagnostic des cancers du poumon, de l'introduction en 2013 d'un programme de dépistage par tomographie numérique à faible dose de rayonnements ionisants
Randomized trials show that screening of high risk populations for lung cancer with annual low dose computed tomography reduces lung cancer and all cause mortality through the earlier detection of non-small cell lung cancer (NSCLC). Lung cancer remains the world’s leading cause of death due to cancer, largely because most cases are diagnosed at an advanced and incurable stage. The goal of screening populations at high risk is to detect cancers at earlier, curable stages, ultimately preventing deaths from lung cancer.
BMJ , éditorial en libre accès, 2021